^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Diffuse Large B Cell Lymphoma |
| Regimen: | RICE (carboplatin + etoposide IV + ifosfamide + Rituxan (rituximab)) |
| Direction: | Sensitive |
Evidence:
Source:
Published date:
01/20/2021
Excerpt:
Diffuse large B-Cell Lymphoma: SECOND-LINE AND SUBSEQUENT THERAPY…Preferred Regimens…ICE (ifsofamide, carboplatin, etoposide) ± rituximab
